Sabah Oney

Chief Executive Officer

2023 - Current

Co-Founder, Interim CEO, Member Board of Directors

2022

Venture Partner

2021

Chief Business Officer

2018 - 2021

Areas of responsibility include: • Finance: Leading multiple private and public fundraising rounds totaling >$570M, including the IPO in 2019 • Partnering and business development: Including a $1.3B global partnership with AbbVie • Public facing functions: Including PR and IR • Facilities, IT: Including Alector’s new 105,000 sq ft HQ in South San Francisco

Vice President, Business Development and Operations

2016 - 2018

Head of Global Sales and Business Development

2015 - 2016

Director of Business Development

2012 - 2016

MBA Intern

2011 - 2011

Pipeline & Portfolio Planning (PPP) M.B.A. Intern Partnered with PPP Senior Director to formulate mid- to long-term China corporate strategy, focusing on target market and growth forecasts Diligenced scientific and financial prospects of eight start-up biotechnology companies; presented recommendations to BD oncology head and team for consideration as potential acquisition targets Evaluated project return metrics (ROI) of early stage pipeline, resulting in recommendations to improve decision making

Senior Scientist

2008 - 2010

Involved in the establishment of the application of b3 bio's technology, leading to partnership with a major pharmaceutical company Partnered with the C.E.O. for business planning and developing mid- to long- term company strategy Coordinated a team of scientists through the conception and development of the scientific projects at b3 bio